Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Gross Profit: 2016-2025

Historic Gross Profit for Anaptysbio (ANAB) over the last 9 years, with Sep 2025 value amounting to $76.3 million.

  • Anaptysbio's Gross Profit rose 154.26% to $76.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.4 million, marking a year-over-year increase of 164.73%. This contributed to the annual value of $91.3 million for FY2024, which is 432.03% up from last year.
  • According to the latest figures from Q3 2025, Anaptysbio's Gross Profit is $76.3 million, which was up 242.81% from $22.3 million recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Gross Profit ranged from a high of $76.3 million in Q3 2025 and a low of $970,000 during Q1 2022.
  • Moreover, its 3-year median value for Gross Profit was $11.0 million (2024), whereas its average is $19.7 million.
  • In the last 5 years, Anaptysbio's Gross Profit crashed by 98.31% in 2021 and then surged by 804.67% in 2024.
  • Over the past 5 years, Anaptysbio's Gross Profit (Quarterly) stood at $1.0 million in 2021, then surged by 394.56% to $5.0 million in 2022, then surged by 80.10% to $9.0 million in 2023, then soared by 177.62% to $25.0 million in 2024, then surged by 154.26% to $76.3 million in 2025.
  • Its Gross Profit stands at $76.3 million for Q3 2025, versus $22.3 million for Q2 2025 and $27.8 million for Q1 2025.